Skip to Content
Skip to Content

Regulatory management option analysis

The regulatory management option analysis (RMOA) list includes substances for which an RMOA either is under development or has been completed since the start of the implementation of the SVHC Roadmap in February 2013.

For each substance, the table shows the assessing Member State (submitter), the concern, the outcome and the suggested follow-up from the RMOA, and the date of the latest update to the list entry.

Other process details and relevant documents are also available and can be accessed through the ‘Details’ icon for the list entry.

 

Disclaimer to the RMOA list

The responsibility for the content of an RMOA rests with the authority that developed it. It is possible that other authorities do not have the same view, and even develop a further RMOA. Any authority can consequently initiate a regulatory process but should indicate this by appropriate means, such as the Registry of Intentions.

RMOAs and their conclusions are compiled based on available information and may change in light of new information or further assessment.

Last updated 17 July 2020. Database contains 249 unique substances/entries.
Filter the list
Date of intention:
Date of RMOA conclusion:
Latest update:

 
219-799-4
2536-05-2
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
214-012-0
1072-63-5
Sweden
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
07/01/2020
Details
212-828-1
872-50-4
Commission
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
25/10/2018
Details
3-benzylidene camphor; 3-BC
239-139-9
15087-24-8
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
covering any of its individual anti- and syn-isomers or any combination thereof
-
-
United Kingdom
Bioaccumulation
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/08/2018
Details
221-641-4
3173-72-6
Germany
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Restriction
10/10/2019
Details
204-661-8
123-91-1
Germany
Bioaccumulation
Persistence
Concluded
Appropriate to initiate regulatory risk management action
SVHC
Restriction
23/06/2020
Details
214-317-9
1120-71-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
06/02/2015
Details
220-474-4
2778-42-9
Germany
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
23/09/2014
Details
214-946-9
1222-05-5
France
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
Other
28/01/2020
Details
203-444-5
106-93-4
ECHA
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
Other
Other legislation
07/08/2015
Details
271-094-0
68515-51-5
Sweden
Carcinogenic
Mutagenic
Toxic for reproduction
Concluded
Appropriate to initiate regulatory risk management action
SVHC
13/01/2015
Details
253-242-6
36861-47-9
Germany
Endocrine disruption
Concluded
Appropriate to initiate regulatory risk management action
SVHC
10/07/2015
Details
-
-
Denmark
Respiratory sensitiser
Concluded
Appropriate to initiate regulatory risk management action
Restriction
06/02/2015
Details
242-060-2
18172-67-3
Greece
Respiratory sensitiser
Skin sensitiser
Concluded
Appropriate to initiate regulatory risk management action
CLH
05/07/2017
Details

Export search results to:

Categories Display


Route: .live1